Stock listing

T3X Stock Price, News, Filings & Events — Telix Pharmaceuticals Limited

Selected listing: T3X · TRADEGATE · EUR · DE

T3X:TRADEGATE represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. The company is actively engaged in advancing its clinical pipeline and has been involved in recent developments that may impact its market position. Investors can stay updated on Telix's latest news, regulatory filings, and upcoming events that could influence its performance in the healthcare sector. The company's strategic initiatives and research efforts are key factors to watch in the evolving landscape of oncology treatments.

T3X:TRADEGATEEURDEUpdated July 21, 2026
Telix Pharmaceuticals Limited logo
Ticker
T3X:TRADEGATE
Asset type
Stock
Market cap
$3.71B
Sector
Health Technology
Industry
Biotechnology
Exchange
TRADEGATE
Currency
EUR

Telix Pharmaceuticals Limited T3X:TRADEGATE stock context

T3X:TRADEGATE represents Telix Pharmaceuticals Limited, a biopharmaceutical company focused on developing and commercializing innovative radiopharmaceuticals for the treatment of cancer and other serious diseases. The company is actively engaged in advancing its clinical pipeline and has been involved in recent developments that may impact its market position. Investors can stay updated on Telix's latest news, regulatory filings, and upcoming events that could influence its performance in the healthcare sector. The company's strategic initiatives and research efforts are key factors to watch in the evolving landscape of oncology treatments.

Research Telix Pharmaceuticals Limited

Alternate listings